April 2023 Publications
- Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment. Rangaka MX, Frick M, Churchyard G, García-Basteiro AL, Hatherill M, Hanekom W, Hill PC, Hamada Y, Quaife M, Vekemans J, White RG, Cobelens F. Lancet Respir Med. 2023 Apr. doi: 10.1016/S2213-2600(23)00084-X. Epub 2023 Mar 23.
- The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Deol A, Scarponi D, Iskauskas A, Bakker R, Quaife M, Malhotra S, Gebreselassie N, Zignol M, Hutubessy RCW, Giersing B, Jit M, Harris RC, Menzies NA, White RG. Lancet Glob Health. 2023 Apr. doi: 10.1016/S2214-109X(23)00045-1.
- Bacillus Calmette-Guérin-induced interleukin-10 inhibits S100A8/A9 production and hinders development of T helper type 1 memory in mice. Wang Y, Sun Y, Zheng Y, Yang Y, He L, Qu P, Zhou F, Xu X, Bai X, Chen X, Yuan Y, Liu M, Pan Q. Eur J Immunol. 2023 Apr. doi: 10.1002/eji.202250204. Epub 2023 Feb 16.
- Planning to introduce novel tuberculosis vaccines in high burden settings: how could this be done?. Cotton MF, Rabie H. Lancet Glob Health. 2023 Apr. doi: 10.1016/S2214-109X(23)00123-7.
- Advances in computational frameworks in the fight against TB: The way forward. Naidu A, Nayak SS, Lulu S S, Sundararajan V. Front Pharmacol. 2023 Apr 3. doi: 10.3389/fphar.2023.1152915. eCollection 2023.
- Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control. Swanson RV, Gupta A, Foreman TW, Lu L, Choreno-Parra JA, Mbandi SK, Rosa BA, Akter S, Das S, Ahmed M, Garcia-Hernandez ML, Singh DK, Esaulova E, Artyomov MN, Gommerman J, Mehra S, Zuniga J, Mitreva M, Scriba TJ, Rangel-Moreno J, Kaushal D, Khader SA. Nat Immunol. 2023 Apr 3. doi: 10.1038/s41590-023-01476-3. Online ahead of print.
- Comparative transcriptomes reveal pro-survival and cytotoxic programs of mucosal-associated invariant T cells upon Bacillus Calmette-Guérin stimulation. Sharma M, Niu L, Zhang X, Huang S. Front Cell Infect Microbiol. 2023 Apr 6. doi: 10.3389/fcimb.2023.1134119. eCollection 2023.
- Mycobacterium tuberculosis-Specific CD4 T Cells Expressing Transcription Factors T-Bet or RORγT Associate with Bacterial Control in Granulomas. Grant NL, Kelly K, Maiello P, Abbott H, O’Connor S, Lin PL, Scanga CA, Flynn JL. mBio. 2023 Apr 11. doi: 10.1128/mbio.00477-23. Online ahead of print.
- Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques. Larson EC, Ellis AL, Rodgers MA, Gubernat AK, Gleim JL, Moriarty RV, Balgeman AJ, Menezes YK, Ameel, CL, Fillmore DJ, Pergalske SM, Juno JA, Maiello P, White AG, O’Connor SL, Scanga CA. Infect Immun. 2023 Apr 11. doi: 10.1128/iai.00558-22. Online ahead of print.
- An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management. Chopra H, Mohanta YK, Rauta PR, Ahmed R, Mahanta S, Mishra PK, Panda P, Rabaan AA, Alshehri AA, Othman B, Alshahrani MA, Alqahtani AS, Al Basha BA, Dhama K. Pharmaceuticals (Basel). 2023 Apr 12. doi: 10.3390/ph16040581.
- Progress on specific and non-specific immune effects of Bacille Calmette-Guerin (Chinese). Su Y, Cao Y, Wang RL, Dong EJ, Zhao WJ, Du JL. Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12. doi: 10.3760/cma.j.cn112147-20220711-00589.
- PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses In Silico and In Vitro Assays. Fan Jiang F, Peng C, Cheng P, Wang J, Lian J, Gong W. Vaccines (Basel). 2023 Apr 17. doi: 10.3390/vaccines11040856.
- BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release. Owusu DO, Adankwah E, Aniagyei W, Acheampong I, Minadzi D, Yeboah A, Arthur JF, Lamptey M, Vivekanandan MM, Abass MK, Kumbel F, Osei-Yeboah F, Gawusu A, Debrah LB, Debrah A, Mayatepek E, Seyfarth J, Phillips RO, Jacobsen M. Vaccines (Basel). 2023 Apr 17. doi: 10.3390/vaccines11040855.
- Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. Shurygina AP, Zabolotnykh N, Vinogradova T, Khairullin B, Kassenov M, Nurpeisova A, Sarsenbayeva G, Sansyzbay A, Vasilyev K, Buzitskaya J, Egorov A, Stukova M. Int J Mol Sci. 2023 Apr 18. doi: 10.3390/ijms24087439.
- Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit. Yadav J, Phogat S, Chaudhary D, Jaiwal R, Jaiwal PK. Biotechnol Lett. 2023 Apr 19. doi: 10.1007/s10529-023-03371-1.
- Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I. Leddy O, White FM, Bryson BD. Elife. 2023 Apr 19. doi: 10.7554/eLife.84070. Online ahead of print.
- In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis. Martinez-Olivares CE, Hernández-Pando R, Mixcoha E. PLoS One. 2023 Apr 20. doi: 10.1371/journal.pone.0284264.
- A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice. Yu J, Fan X, Luan X, Wang R, Cao B, Qian C, Li G, Li M, Zhao X, Liu H, Wan K, Yuan X. Front Immun. 2023 Apr 21. doi: 10.3389/fimmu.2023.1138818.
- Genetic epidemiology of resistance to M. tuberculosis Infection: importance of study design and recent findings. Stein CM. Genes Immun. 2023 Apr 22. doi: 10.1038/s41435-023-00204-z. Online ahead of print.
- Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques. Hoft SG, Kauffman KD, Sakai S, Lindestam Arlehamn CS, Sette A, Hoft DF, Herbert R, Barber DL. mBio. 2023 Apr 25. doi: 10.1128/mbio.00220-23. Epub 2023 Mar 7.
- Peptide microarray-based identification of dormancy-associated Mycobacterium tuberculosis antigens inducing immune responses among latent tuberculosis infection individuals in Thailand. Hanthamrongwit J, Aruvornlop P, Saelee C, Wanta N, Poneksawat P, Soe PT, Kyaw SP, Khaenam P, Warit S, Valentini D, Mahasirimongkol S, Dhepakson P, Soonthornchartrawat S, Chootong P, Leepiyasakulchai C. Sci Rep. 2023 Apr 28. doi: 10.1038/s41598-023-34307-4.